With the “Cancer Moonshot” calling for the acceleration of oncology research, the biotech industry is racing to create a new generation of cancer killers. Having learned from the successes and challenges of traditional treatment modalities, companies are developing a powerful new wave of cancer-fighting tools. Aided by the latest genomic and computational technology, innovators in oncology research are developing novel therapies to transcend the limitations of available cancer treatments. These approaches include developing a universal cellular immunotherapy to treat multiple cancers, unlocking the potential of bicyclic peptides to target tumors, creating oncolytic viruses to kill cancer cells but avoid healthy cells and developing next-generation active immunotherapies that enable the body’s immune system to fight cancer.
This panel brings together experts in oncology research and development who will discuss the limits of current approaches, the promise of combination therapies and emerging technologies that may result in giant leaps forward for cancer research.
Session ID: 22110